Medline Inc. (MDLN) Enterprise Value (EV): $44.73B
The enterprise value (EV) for Medline Inc. (MDLN) is $44.73B as of Thursday, June 11, 2026.
MDLN Enterprise Value (EV) Metrics
ENTERPRISE VALUE (EV)
$44.73B
MDLN Competitors' Enterprise Value (EV)
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Medline Inc. (MDLN) | $30.90B | $44.73B |
| IQVIA Holdings Inc. (IQV) | $30.60B | $52.94B |
| Centene Corporation (CNC) | $31.94B | $21.10B |
| DexCom, Inc. (DXCM) | $29.24B | $26.37B |
| Biogen Inc. (BIIB) | $29.00B | $29.76B |
| Zoetis Inc. (ZTS) | $34.20B | $62.97B |
| Veeva Systems Inc. (VEEV) | $26.73B | $32.05B |
| Agilent Technologies, Inc. (A) | $37.17B | $42.98B |
| Waters Corporation (WAT) | $23.83B | $23.51B |
| Mettler-Toledo International Inc. (MTD) | $22.85B | $31.01B |
Enterprise Value Calculation
Market Cap
$30.90B
Total Debt
$12.56B
Cash
$1.94B
Enterprise Value
$44.73B
EV-Based Valuation Multiples
Why use EV instead of Market Cap?
- EV accounts for debt - an acquirer must pay or assume it
- EV deducts cash - the acquirer effectively receives it
- EV enables fair comparison of companies with different capital structures
- EV-based ratios (EV/EBITDA, EV/Sales) are capital structure neutral
Medline Inc. Enterprise Value (EV) Formula & Definition
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Medline Inc. Enterprise Value (EV) FAQ
- What is the enterprise value (EV) for Medline Inc. (MDLN)?
- The enterprise value (EV) for MDLN stock is $44.73B.
Related Metrics
About Medline Inc.
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- James Boyle